Alzheimer's Disease Trial, Recruiting NCT06608589 Sponsor: Laval University Condition: Alzheimer's Disease
Back to Alzheimers Disease

Alzheimer's Disease Trial, Recruiting

NCT06608589
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Group 1 – People living with a major brain/memory disorder and their caregivers:

  • People aged 65 or older who are currently being assessed for, or have already been diagnosed with, a serious memory or brain disorder (such as dementia)
  • People who live in the CISSS CA health region (a specific regional health authority in Quebec)
  • People who live at home, in a retirement home, an intermediate residence, or a family-type care setting
  • People who are able to give their own consent to participate in research
  • People who agree to allow the research team to access relevant medical records

OR

  • People who are a caregiver for someone aged 65 or older living with a serious memory or brain disorder (diagnosed or being assessed), where that person lives in the CISSS CA region
  • Caregivers who are able to give their own consent to participate in research
  • Caregivers who agree to allow the research team to access the medical records of the person they care for

Group 2 – People attending CoMPAS+ program workshops:

  • Health professionals working at a CISSS CA health facility or with a community organisation
  • Decision-makers or local managers within the CISSS CA
  • Representatives of community services (for example, the Alzheimer's Society or L'APPUI)

Group 3 – People involved in implementing the CoMPAS+ program:

  • Health professionals, decision-makers, community service representatives, caregivers, users, workshop facilitators, INESSS professionals, certain research team members (as specified by the trial), and representatives of the Quebec Ministry of Health and Social Services (MSSS), where they are actively involved in putting the CoMPAS+ program into practice

Who may not be able to join:

Group 1 – People living with a memory/brain disorder and their caregivers:

  • People under 65 years of age living with a serious memory or brain disorder
  • People who are already living in a provincial long-term care facility at the time of recruitment
  • People aged 65 or older with a serious memory or brain disorder who cannot give their own consent and who have no caregiver, or whose caregiver is also unable to give consent independently
  • People who live outside the CISSS CA health region
  • People who do not agree to allow the research team to access their medical records
  • Caregivers of people who do not live in the CISSS CA region, are under 65, do not live in an eligible setting (home, retirement home, intermediate residence), or who passed away before the study began
  • Caregivers who do not agree to allow the research team to access the medical records of the person they care for

Group 2 – Workshop participants:

  • Members of the research team
  • Workshop facilitators
  • INESSS professionals
  • People who are users or partner caregivers (in this group specifically)
  • Anyone unable to give their own consent
  • Anyone who does not agree to participate

Group 3 – People involved in program implementation:

  • Anyone unable to give their own consent
  • Anyone who does not agree to participate
  • Specific named members of the research team responsible for leading or coordinating this part of the study (Laetitia Bert, Alexander Cornea, Martyne Audet, Clémence Dallaire, André Côté, Félix Pageau, and Catherine Paquet)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Patrick M Archambault, MD, MSc, FRCPC, Laval University

Phone: 4189552552

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Laval University
Registry
ClinicalTrials.gov
Start date
14 March 2023
Est. completion
30 April 2026

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Perceived quality of care: The variation in the Physician Enabling Skills Questionnaire (PESQ) scores.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov